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Carbapenems are antimicrobial drugs of last re-sort for infections caused by multidrug-resistant 
gram-negative bacteria. Therefore, the global spread 
of carbapenemase-producing Enterobacteriaceae, 
which are resistant to carbapenems, is troubling (1,2). 
Because of the high number of deaths associated with 
infections caused by these bacteria, the World Health 
Organization classifies Enterobacteriaceae as priority 
organisms for which new antimicrobial drugs are ur-
gently needed (3).
Oxacillinase (OXA)-48–like carbapenemases are 
among the most common carbapenemases in Entero-
bacterales; of the OXA-48–like enzymes, OXA-181 is 
the second most common type (2). OXA-48 Klebsiella 
pneumoniae is considered endemic to North Africa 
and the Middle East; OXA-181 Klebsiella pneumoniae is 
endemic to the Indian subcontinent. However, noso-
comial outbreaks of OXA-181 have occurred in sub-
Saharan Africa (2). We describe the epidemiology 
and clonal spread of OXA-181–producing Klebsiella 
pneumoniae in a neonatal intensive care unit (NICU) 
in Ghana. The Institutional Review Board of the Kor-
le-Bu Teaching Hospital granted ethics approval (no. 
IRB/0025/2017) for this study.
The Study
We whole-genome sequenced 29 carbapenemase-pro-
ducing K. pneumoniae isolates: 18 from neonatal car-
riage (isolates from swabs of neonates) (4), 3 from the 
NICU environment (cots and trolley handles), and 8 
from neonatal bloodstream infections. These samples 
were isolated from the NICU of Korle-Bu Teaching 
Hospital (Accra, Ghana) from September 2017 through 
February 2019 (5) (Table; Appendix, https://wwwnc.
cdc.gov/EID/article/26/9/20-0562-App1.pdf).
Twenty-eight of the 29 isolates were sequence 
type (ST) 17 and capsular type KL25. We excluded 
1 isolate from further analysis that was ST48 and 
KL64. Core-genome phylogeny showed a close 
genetic relationship of all ST17 isolates (0–32 sin-
gle-nucleotide polymorphism [SNP] differences; 
median 5 SNP differences), suggesting a localized 
outbreak (Figure 1). We estimated that the most re-
cent common ancestor of the outbreak emerged in 
April 2017 (year 2017.3; 95% highest posterior den-
sity interval 2017.0–2017.6) with an estimated mean 
substitution rate of 2.1 × 10–6 SNPs/site/year (9.9 
SNPs/year) (Appendix Figure).
All isolates were resistant to amoxicillin/cla-
vulanic acid, gentamicin, amikacin, cefuroxime, 
ceftriaxone, ceftazidime, tazobactam/piperacillin, 
and ciprofloxacin. The isolates were susceptible to 
colistin and had MICs of <1 µg/mL. All outbreak 
isolates harbored the carbapenemase blaOXA-181 and 
extended-spectrum β-lactamase blaCTX-M-15 in addi-
tion to other β-lactamases (blaTEM-1B, blaSHV-94). We 
also found several genes encoding resistance to 
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We sequenced 29 carbapenemase-producing Klebsiella 
pneumoniae isolates from a neonatal intensive care unit 
in Ghana. Twenty-eight isolates were sequence type 17 
with blaOXA-181 and differed by 0–32 single-nucleotide poly-
morphisms. Improved surveillance and infection control 
are needed to characterize and curb the spread of multi-
drug-resistant organisms in sub-Saharan Africa.
DISPATCHES
other antimicrobial drugs: aminoglycosides (rmtB, 
aph(3′’)-Ib, aph(3′)-Ia, aph(6)-Id, aac(3)-IId, aadA2, 
aadA2b); fluoroquinolones (qnrS, oqxA, oqxB); fos-
fomycin (fosA); macrolide (mph (A)); phenicols 
(catA2); sulphonamides (sul2, sul1); tetracyclines 
(tetA, tetG); and trimethoprim (dfrA12, dfrA14) 
(Figure 1).
All isolates contained 4 common plasmid incom-
patibility (Inc) groups (IncX3, IncF1B (Mar), IncQ1, 
IncColKP3). Eighteen isolates also contained incom-
patibility groups IncFIB (K) and IncFII, and 3 con-
tained additional IncColRNA (Figures 1, 2). Further 
analysis revealed that recently recovered isolates had 
more plasmid Inc groups than did older isolates (Fig-
ure 1). The accessory genome of the isolates showed 
large variation in gene content (Figure 2). These data 
illustrate that this variation existed at the time of the 
first sampling in September 2017, when the isolates 
formed 3 distinct clusters (Figure 2). The clustering is 
associated with differences in plasmid content of the 
isolates and represents the uptake or loss of 205 genes. 
On the basis of the phylogeny and metadata, we hy-
pothesize that 4 major evolutionary events caused 
changes in Inc groups and the ancestor of the cluster 
of isolates with Inc groups IncX3, IncFIB, IncQ1 and 
ColKP3 (Figure 2).
A study in South Africa identified a fully closed 
plasmid carrying blaOXA-181 (6). Using the short-read se-
quencing applied in this study, we cannot determine 
whether blaOXA-181 is carried on a plasmid or located 
in the chromosome. Mapping of raw reads toward 
the fully closed plasmid reveals complete coverage 
across the whole plasmid for 24 of the 28 isolates; 
the remaining 4 most recent isolates had reads 
covering the whole plasmid (except for 4 genes). 
This finding might indicate these isolates have 
a similar plasmid containing blaOXA-181, although 
we cannot rule out that these reads might belong 
to other related plasmids and not the previously 
reported plasmid (6).
Conclusions
We identified an outbreak of ST17 K. pneumoniae 
carrying blaOXA-181 in a NICU in Ghana. Outbreak 
isolates were resistant to all antimicrobial drugs 
commonly used to treat neonatal infections (al-
though it was susceptible to colistin). Similar out-
breaks of ST17 OXA-181–producing K. pneumoniae 
have been documented in South Africa (7), further 
confirming the spread of this type of resistance 
into nonendemic regions (2). Time-based phyloge-
netic analysis showed the outbreak isolates share 
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Figure 1. Phylogenetic tree of 28 carbapenemase-producing Klebsiella pneumoniae isolates and their acquired resistance genes from 
the neonatal intensive care unit at Korle-Bu Teaching Hospital, Accra, Ghana, 2017–2019. The tree was produced by analysis of single-
nucleotide polymorphisms (SNPs) of core genomes. Maximum genetic distance was between isolates KP2201 and KP026, which differed 
by 32 SNPs. Tree used genome of K. pneumoniae reference strain HS11286 as outgroup. Lane 1, rmtB; lane 2, aph(3”)-lb; lane 3, aph(3’)-
la; lane 4, aph(6)-ld; lane 5, aac(3)-lld; lane 6, aadA2; lane 7, aadA2b; lane 8, blaOXA-181; lane 9, blaTEM-1B; lane 10, blaSHV-94; lane 
11, blaCTX-M-15; lane 12, qnrS; lane 13, oqxA; lane 14, oqxB; lane 15, fosA; lane 16, mph(A); lane 17, catA2; lane 18, sul2; lane 19, sul1; 
lane 20, tetA; lane 21, tetG; lane 22, dfrA12; lane 23, drfA14. Scale bar indicates substitutions per site.
K. pneumoniae in Neonatal Intensive Care Unit
a recent ancestor (approximately April 2017). This 
finding suggests that the outbreak strain had been 
introduced recently into the NICU or that the out-
break strain had limited genetic diversity because 
of a recent bottleneck or selective sweep in the out-
break strain population.
K. pneumoniae is an entry point of antimicro-
bial resistance into the family Enterobacteriaceae (8). 
Thus, carbapenemase-producing K. pneumoniae in 
the NICU might transmit resistance to other En-
terobacteriaceae species. Other studies have associ-
ated blaOXA-181 with the insertion sequence element 
ISEcp1, which can spread cephalosporinases and 
extended-spectrum β-lactamases (9). In our study, 
all isolates possessed the IncX3 plasmid. This 
plasmid is self-transmissible and associated with 
worldwide dissemination of New Delhi metallo-
β-lactamases 1 and 5 (10,11). Recent studies from 
countries in Africa have found blaOXA-181 carried on 
the IncX3 plasmid in Enterobacteriaceae species, in-
cluding K. pneumoniae (2,6,7).
In Europe, the spread of carbapenem-resistant 
K. pneumoniae has been driven by 4 carbapenemase-
positive clonal lineages that are often transmitted in 
hospitals (8). The isolates from the NICU were genet-
ically diverse, especially in the plasmid content of the 
accessory genome. This diversity indicates the ge-
nome evolved rapidly, similar to isolates from an 
outbreak of K. pneumoniae in Beijing, China. In the 
outbreak in China, the isolates underwent rapid 
genotypic evolution mainly through rearrange-
ment (including the gain and loss of genes) in the 
accessory genome (12). Antimicrobial pressure 
in hospitals might lead to adaptation and resis-
tance transmission of K. pneumoniae in the hospital 
environment (8).
From our data, we infer the background trans-
mission of carbapenemase-producing K. pneumoniae 
in the NICU before its detection. Neonatal carriage 
or environmental contamination by carbapenemase-
producing K. pneumoniae might have started or 
maintained the outbreak. Improved surveillance of 
multidrug-resistant organisms, buttressed with im-
proved infection prevention and control activities, 
are required to detect and control outbreaks in low-
resource settings.
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Figure 2. Binary rational tree 
illustrating genetic diversity 
(presence–absence of genes) 
of the accessory genome of 
carbapenemase-producing 
Klebsiella pneumoniae isolates 
from the neonatal intensive 
care unit at Korle-Bu Teaching 
Hospital, Accra, Ghana, 2017–
2019. Different shapes represent 
different dates of organism 
isolation. Blue and green shapes 
evolved from the gray; pink and 
yellow evolved from the blue. 
Scale bar indicates genetic 
differences per site.
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